First Over-the-Counter Continuous Glucose Monitor Launches with Dexcom's Stelo
First Over-the-Counter Continuous Glucose Monitor
In a significant advancement for diabetes management, Dexcom has launched its Stelo, making it the first continuous glucose monitor (CGM) available over-the-counter. This innovation aims to empower individuals over 18 years living with diabetes or prediabetes, specifically those not currently using insulin or at risk of hypoglycemia.
Key Features of Dexcom's Stelo
- No Prescription Required: Dexcom's Stelo is accessible without a prescription, increasing availability for patients.
- Targeted User Group: Designed for adults aged 18 and older, focusing on those with diabetes or prediabetes.
- Enhanced Monitoring: The device provides real-time glucose level tracking, aiming to improve day-to-day management.
What This Means for Consumers
This launch is a game-changer for diabetes management, offering users more freedom and immediate access to their health data. As diabetes becomes increasingly prevalent, devices like Stelo could be instrumental in preventing complications and enhancing life quality.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.